1329P Immune checkpoint inhibitors in advanced NSCLC patients with poor performance status: The role of clinical-pathological variables and inflammatory biomarkers in a real world experience

Authors :: Roberto Ferrara
C.M. Della Corte
Floriana Morgillo
Giulia Galli
Francesca Sparano
R. Di Liello
Marina Chiara Garassino
Monica Ganzinelli
Arsela Prelaj
Giuseppe Viscardi
Marta Brambilla
G. Lo Russo
Riccardo Lobefaro
Claudia Proto
Benedetta Trevisan
Diego Signorelli
A. De Toma
Maria Lucia Iacovino
Giacomo Massa
F. de Braud
Source :: Annals of Oncology. 31:S856-S857
Publication Year :: 2020
Publisher :: Elsevier BV, 2020.

Subjects :: Oncology
medicine.medical_specialty
business.industry
Internal medicine
Immune checkpoint inhibitors
medicine
Poor performance status
Hematology
business
Pathological
Inflammatory biomarkers

Full Text Access

Tools